Background {#Sec1}
==========

AD is the most common form of dementia with severe personal, social, and economic impacts. Rare, familial forms of AD exist caused by autosomal dominant mutations in single genes (reviewed by \[[@CR1]\]). The majority of these mutations occur in the gene *PRESENILIN 1* (*PSEN1*) that encodes a multipass integral membrane protein involved in intra-membrane cleavage of numerous proteins \[[@CR1]\].

A wide variety of transgenic models of AD have been created and studied. These are aimed at reproducing histopathologies posited to be central to the disease process, i.e. amyloid plaques and neurofibrillary tangles of the protein MAPT \[[@CR2]\]. However, analysis of the effects on the brain transcriptome of the transgenes driving a number of these mouse models showed little concordance with transcriptomic differences between human AD brains and age-matched controls \[[@CR3]\] (although a recent study asserts that this lack of concordance for the popular "5XFAD" transgenic mouse model is due to previous failure to analyse the effects of its transgenes in a variety of genetic backgrounds \[[@CR4]\]). We posit that, in the absence of an understanding of the molecular mechanism(s) underlying AD, the most objective approach to modeling this disease (or, at least, modeling its genetic form, EOfAD) is to create a genetic state as similar as possible to the EOfAD state in humans. Mouse "knock-in" models of EOfAD mutations were created over a decade ago and showed subtle phenotypic effects but not the desired histopathologies (e.g. \[[@CR5], [@CR6]\]). However, at that time, researchers did not have access to RNA-Seq technology. To the best of our knowledge, transcriptome analysis of the EOfAD mutation knock-in mouse models was never performed.

In humans, AD is thought to develop over decades and the median survival to onset age for EOfAD mutations in human *PSEN1* considered collectively is 45 years \[[@CR7]\]. Functional MRI of human children carrying EOfAD mutations in *PSEN1* has revealed differences in brain activity compared to non-carriers in individuals as young as 9 years of age \[[@CR8]\]. Presumably therefore, heterozygosity for EOfAD mutations in *PSEN1* causes early molecular changes/stresses that eventually lead to AD.

Transcriptome analysis is currently the most detailed molecular phenotypic analysis possible on cells or tissues. Here we present an initial analysis of the transcriptomic differences caused in young adult (6-month-old) zebrafish brains by the presence of an EOfAD-like mutation in the gene *psen1* that is orthologous to the human *PSEN1* gene. GO analysis supports very significant effects on mitochondrial function, especially synthesis of ATP, and on ATP-dependent functions such as the acidification of lysosomes that are critical for autophagy.

Materials and methods {#Sec2}
=====================

The mutant allele, Q96_K97del, of *psen1* was a byproduct identified during our introduction of the K97fs mutation into *psen1* (that models the K115fs mutation of human *PSEN2* -- see \[[@CR9]\] for an explanation).

Q96_K97del is a deletion of 6 nucleotides from the coding sequence of the *psen1* gene. This is predicted to distort the first lumenal loop of the Psen1 protein. In this sense, it is similar to a number of EOfAD mutations of human *PSEN1* \[[@CR10]\]. Also, in common with all the widely distributed EOfAD mutations in *PSEN1*, (and consistent with the PRESENILIN EOfAD mutation "reading frame preservation rule" \[[@CR1]\]), the Q96_K97del allele is predicted to encode a transcript that includes the C-terminal sequences of the wild type protein. Therefore, as a model of an EOfAD mutation, it is superior to the K97fs mutation in *psen1* \[[@CR9]\].

To generate a family of heterozygous Q96_K97del allele (i.e. *psen1*^*Q96_K97del*^/+) and wild type (+/+) sibling fish, we mated a *psen1*^*Q96_K97del*^/+ individual with a +/+ individual and raised the progeny from a single spawning event together in one tank. Zebrafish can live for up to 5 years but, in our laboratory, typically show greatly reduced fertility after 18 months. The fish become fertile after around 3 months of age, so we regard 6-month-old fish as equivalent to young adult humans. Therefore we analysed the transcriptomes of entire young adult, 6-month-old fish brains using poly-A enriched RNA-seq technology, and estimated gene expression from the resulting single-end 75 bp reads using the reference GRCz11 zebrafish assembly transcriptome \[[@CR11], [@CR12]\]. Each zebrafish brain has a mass of approximately 7 mg. Since AD is more prevalent in human females than males, and to further reduce gene expression "noise" in our analyses, we obtained brain transcriptome data from four female wild type fish and four female heterozygous mutant fish. This data has been made publicly available at the Gene Expression Omnibus (GEO, see under *Availability of data and materials* below).

Results {#Sec3}
=======

Differentially expressed genes (DE genes) {#Sec4}
-----------------------------------------

Genes differentially expressed between wild type and heterozygous mutant sibling fish were identified using moderated *t*-tests and a false discovery rate (FDR)-adjusted *p*-value cutoff of 0.05 as previously described \[[@CR9], [@CR13], [@CR14]\]. In total, 251 genes were identified as differentially expressed (see Additional file [1](#MOESM1){ref-type="media"}). Of these, 105 genes showed increased expression in heterozygous mutant brains relative to wild type sibling brains while 146 genes showed decreased expression.

GO analysis {#Sec5}
-----------

To understand the significance for brain cellular function of the differential gene expression identified in young adult heterozygous mutant brains we used the *goana* function \[[@CR15]\] of the *limma* package of Bioconductor software \[[@CR14]\] to identify GOs in which the DE genes were enriched at an FDR-corrected *p*-value of less than 0.05. Seventy-eight GOs were identified (Table [1](#Tab1){ref-type="table"}) of which 20 addressed cellular components (CC). Remarkably, most of these CCs concerned the mitochondrion, membranes, or ATPases. Seventeen GOs addressed molecular functions (MF) and largely involved membrane transporter activity, particularly ion transport and ATPase activity coupled to such transport. Forty-one GOs addressed biological processes (BP) and involved ATP metabolism, ribonucleoside metabolism, and transmembrane transport processes including vacuolar acidification (that has previously been identified as affected by EOfAD mutations in *PSEN1* \[[@CR16]\]). Overall, our GO analysis indicates that this EOfAD-like mutation of zebrafish *psen1* has very significant impacts on cellular energy metabolism and transmembrane transport processes.Table 1GOs enriched for genes differentially expressed between heterozygous mutant and wild type sibling fish brainsGene Ontology TermOntologyTotal GenesDE Genesp-valueFDR *p*-valueATP biosynthetic processBP2973.48987E-080.00041ribonucleoside triphosphate biosynthetic processBP4989.41317E-080.00045nucleoside triphosphate biosynthetic processBP5482.06555E-070.00060purine nucleoside triphosphate biosynthetic processBP4174.46237E-070.00060purine ribonucleoside triphosphate biosynthetic processBP4174.46237E-070.00060hydrogen transportBP6084.783E-070.00060proton transportBP6084.783E-070.00060energy coupled proton transport, down electrochemical gradientBP2765.89038E-070.00060ATP synthesis coupled proton transportBP2765.89038E-070.00060transportBP2072482.11748E-060.00165purine nucleoside monophosphate biosynthetic processBP5473.09019E-060.00172purine ribonucleoside monophosphate biosynthetic processBP5473.09019E-060.00172hydrogen ion transmembrane transportBP5473.09019E-060.00172ribonucleoside triphosphate metabolic processBP133103.8448E-060.00178establishment of localizationBP2123484.20295E-060.00182ATP metabolic processBP10995.50772E-060.00230nucleoside triphosphate metabolic processBP140106.08925E-060.00245cation transportBP452186.61154E-060.00258monovalent inorganic cation transportBP219121.10729E-050.00392ribonucleoside monophosphate biosynthetic processBP6571.08944E-050.00392nucleoside monophosphate biosynthetic processBP6871.47269E-050.00492purine ribonucleoside triphosphate metabolic processBP12591.68142E-050.00546purine nucleoside triphosphate metabolic processBP12691.79263E-050.00552transmembrane transportBP654212.93288E-050.00797purine nucleoside monophosphate metabolic processBP13693.2951E-050.00837purine ribonucleoside monophosphate metabolic processBP13693.2951E-050.00837energy coupled proton transmembrane transport, against electrochemical gradientBP3555.20342E-050.01106ATP hydrolysis coupled proton transportBP3555.20342E-050.01106ATP hydrolysis coupled transmembrane transportBP3555.20342E-050.01106ATP hydrolysis coupled ion transmembrane transportBP3555.20342E-050.01106ATP hydrolysis coupled cation transmembrane transportBP3555.20342E-050.01106ion transportBP737225.61478E-050.01152localizationBP2621526.0913E-050.01207ribonucleoside monophosphate metabolic processBP14796.06496E-050.01207nucleoside monophosphate metabolic processBP15097.09445E-050.01360single-organism localizationBP819239.51294E-050.01738single-organism transportBP776220.0001190820.02109ribonucleotide biosynthetic processBP12980.0001430280.02423ribose phosphate biosynthetic processBP12980.0001430280.02423vacuolar acidificationBP1130.0002465820.04101ribonucleotide metabolic processBP220100.0002813520.04506proton-transporting two-sector ATPase complex, proton-transporting domainCC2563.59375E-070.00060proton-transporting two-sector ATPase complexCC4578.65692E-070.00078mitochondrial membraneCC285151.42199E-060.00119mitochondrial envelopeCC303153.0322E-060.00172membrane partCC4868851.1722E-050.00403organelle membraneCC789241.84982E-050.00555mitochondrial inner membraneCC195111.97958E-050.00579integral component of membraneCC4419782.52479E-050.00720intrinsic component of membraneCC4453783.37749E-050.00840organelle envelopeCC420163.76291E-050.00917envelopeCC422163.98337E-050.00950organelle inner membraneCC215114.86028E-050.01106Cul2-RING ubiquitin ligase complexCC735.4156E-050.01131proton-transporting ATP synthase complexCC1946.25883E-050.01220mitochondrial membrane partCC11787.21148E-050.01360mitochondrial partCC404158.83156E-050.01639membraneCC5379880.0001069640.01924vacuolar proton-transporting V-type ATPase, V0 domainCC930.0001277330.02229mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)CC1230.0003259330.04885proton-transporting V-type ATPase, V0 domainCC1230.0003259330.04885ATPase activity, coupled to transmembrane movement of ions, rotational mechanismMF3471.1446E-070.00045hydrogen ion transmembrane transporter activityMF8496.11883E-070.00060ATPase activity, coupled to transmembrane movement of substancesMF9892.27123E-060.00166hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substancesMF10192.92425E-060.00172primary active transmembrane transporter activityMF10493.73269E-060.00178P-P-bond-hydrolysis-driven transmembrane transporter activityMF10493.73269E-060.00178cation-transporting ATPase activityMF5673.96731E-060.00178ATPase coupled ion transmembrane transporter activityMF5673.96731E-060.00178ATPase activity, coupled to movement of substancesMF11296.88692E-060.00260active ion transmembrane transporter activityMF9681.72916E-050.00546active transmembrane transporter activityMF281132.87859E-050.00797proton-transporting ATP synthase activity, rotational mechanismMF1643.02121E-050.00803transporter activityMF991250.0002490510.04101substrate-specific transmembrane transporter activityMF709200.0002635280.04279ion transmembrane transporter activityMF660190.0002931840.04572substrate-specific transporter activityMF828220.0002970090.04572monovalent inorganic cation transmembrane transporter activityMF264110.0002972170.04572GOs are grouped by ontology (BP, CC or MF) and ranked by FDR-corrected *p*-value
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===============
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Additional file 1:Genes differentially expressed between heterozygous mutant and wild type brains at 6 months. Lists the genes identified as differentially expressed between the brains of heterozygous *psen1*^*Q96_K97del*^ mutant fish and the brains of their wild type siblings at an age of 6 months. Genes are ranked according to FDR-corrected *p*-value. Only genes with a FDR-corrected p-value less than 0.05 are shown. "FC" denotes fold change. "DE" denotes differential expression. For DE_Direction, "1" denotes increased expression in the mutant and "-1" denotes decreased expression in the mutant. (XLSX 39 kb)
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